Soluble protein oligomers in neurodegeneration: lessons from the Alzheimer's amyloid β-peptide
The DOI matches its Crossref record; 134 of the 135 references it cites were found in a registry or an index.
Abstract
The distinct protein aggregates that are found in Alzheimer's, Parkinson's, Huntington's and prion diseases seem to cause these disorders. Small intermediates - soluble oligomers - in the aggregation process can confer synaptic dysfunction, whereas large, insoluble deposits might function as reservoirs of the bioactive oligomers. These emerging concepts are exemplified by Alzheimer's disease, in which amyloid beta-protein oligomers adversely affect synaptic structure and plasticity. Findings in other neurodegenerative diseases indicate that a broadly similar process of neuronal dysfunction is induced by diffusible oligomers of misfolded proteins.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“This observation suggests that oligodendrocytes could potentially generate a relatively higher proportion of longer Aβ species, which are more prone to aggregation [28]”
From Selective suppression of oligodendrocyte-derived amyloid beta rescues neuronal dysfunction in Alzheimer’s disease (2024) · cites this paper as [28]
In the citing paper
“The increased Aβ 42:40 ratio in oligodendrocytes could contribute to the high proportion of soluble aggregates [28,42,43]”
From Selective suppression of oligodendrocyte-derived amyloid beta rescues neuronal dysfunction in Alzheimer’s disease (2024) · cites this paper as [28]
In the citing paper
“and, consequently, could be more pathogenic than shorter Aβ species”
From Selective suppression of oligodendrocyte-derived amyloid beta rescues neuronal dysfunction in Alzheimer’s disease (2024) · cites this paper as [28]
In the citing paper
“However, recent in vivo studies have shown that soluble Aβ oligomers are more neurotoxic than amyloid plaques and most likely responsible for synaptic dysfunction and memory loss in AD.7–11”
From The effect of Cu2+ and Zn2+ on the Aβ42 peptide aggregation and cellular toxicity (2013) · cites this paper as [8]
In the citing paper
“Dysregulation of A peptide metabolism is hypothesized to initiate pathogenic cascades that lead to Alzheimer's disease (AD) (Haass and Selkoe, 2007).”
From microRNA-33 Regulates ApoE Lipidation and Amyloid-β Metabolism in the Brain (2015) · cites this paper as Haass and Selkoe, 2007
12 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
1 retracted
RETRACTED ARTICLE: A specific amyloid-β protein assembly in the brain impairs memory
Lesné, S., Koh, M. T., Kotilinek, L., Kayed, R., Glabe, C. G., Yang, A., Gallagher, M., & Ashe, K. H. (2006) · Nature · doi:10.1038/nature04533 · Cited by 2,769
RetractedThe Amyloid Hypothesis of Alzheimer’s Disease: Progress and Problems on the Road to Therapeutics
Hardy, J., & Selkoe, D. J. (2002) · Science · doi:10.1126/science.1072994 · Cited by 13,864
Self-citationSpillantini, M. G., Schmidt, M. L., Lee, V. M.-Y., Trojanowski, J. Q., Jakes, R., & Goedert, M. (1997) · Nature · doi:10.1038/42166 · Cited by 8,382
MACDONALD, M. (1993) · Cell · doi:10.1016/0092-8674(93)90585-e · Cited by 8,366
Mutation in the α-Synuclein Gene Identified in Families with Parkinson's Disease
Polymeropoulos, M. H., Lavedan, C., Leroy, E., Ide, S. E., Dehejia, A., Dutra, A., Pike, B., Root, H., Rubenstein, J., Boyer, R., et al. (1997) · Science · doi:10.1126/science.276.5321.2045 · Cited by 8,240
Alzheimer's disease: the amyloid cascade hypothesis
Hardy, J. A., & Higgins, G. A. (1992) · Science · doi:10.1126/science.1566067 · Cited by 7,484 · cited 1×
“These and other findings led to the formal proposal of a hypothesis of disease in which excessive Aβ accumulation and deposition could trigger a complex downstream cascade that resulted in the symptoms of A”
ResultRosen, D. R., Siddique, T., Patterson, D., Figlewicz, D. A., Sapp, P., Hentati, A., Donaldson, D., Goto, J., O'Regan, J. P., Deng, H.-X., et al. (1993) · Nature · doi:10.1038/362059a0 · Cited by 7,062 · cited 1×
“In a similar manner, breakthrough discoveries of causative genes allowed the subsequent identification of aggregation-prone proteins in disorders such as amyotrophic lateral sclerosis (ALS”
ResultUbiquitinated TDP-43 in Frontotemporal Lobar Degeneration and Amyotrophic Lateral Sclerosis
Neumann, M., Sampathu, D. M., Kwong, L. K., Truax, A. C., Micsenyi, M. C., Chou, T. T., Bruce, J., Schuck, T., Grossman, M., Clark, C. M., et al. (2006) · Science · doi:10.1126/science.1134108 · Cited by 6,576 · cited 1×
“More recently, TDP43 was found to be deposited in tau- and synuclein-negative inclusions in a disorder designated as frontotemporal lobar degeneration with ubiquitin-positive inclusions (FTLD-U) as well as in AL”
BackgroundGlenner, G. G., & Wong, C. W. (1984) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(84)80190-4 · Cited by 5,404
Goate, A., Chartier-Harlin, M.-C., Mullan, M., Brown, J., Crawford, F., Fidani, L., Giuffra, L., Haynes, A., Irving, N., James, L., et al. (1991) · Nature · doi:10.1038/349704a0 · Cited by 4,659 · cited 1×
“Shortly thereafter, a distinct APP missense mutation was found in a family with early-onset A”
Background
Cited by
Items 601–700 of 1,119
Tackenberg, C., & Brandt, R. (2009) · The Journal of Neuroscience · doi:10.1523/jneurosci.3590-09.2009 · Cited by 127
“Synaptic alterations as evidenced by a reduction in dendritic spine numbers and changes in spine shape are an early event in AD and are thought to be caused by soluble low-molecular-weight A oligomers (Haass and Selkoe, 2007; Tackenberg et al., 2009).”
BackgroundBarone, E., Di Domenico, F., Mancuso, C., & Butterfield, D. A. (2014) · Neurobiology of Disease · doi:10.1016/j.nbd.2013.09.018 · Cited by 127
“Aβ exists in various soluble and insoluble forms including aggregates, soluble monomers, oligomers, protofibrils, and fibrils (Haass and Selkoe, 2007; Walsh et al., 2002).”
Tampellini, D., Rahman, N., Gallo, E. F., Huang, Z., Dumont, M., Capetillo-Zarate, E., Ma, T., Zheng, R., Lu, B., Nanus, D. M., et al. (2009) · The Journal of Neuroscience · doi:10.1523/jneurosci.2292-09.2009 · Cited by 127
“-Amyloid (A ) accumulation in the brain is a hallmark of Alzheimer’s disease (AD) pathology (Haass and Selkoe, 2007).”
BackgroundBaranger, K., Marchalant, Y., Bonnet, A. E., Crouzin, N., Carrete, A., Paumier, J.-M., Py, N. A., Bernard, A., Bauer, C., Charrat, E., et al. (2016) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-015-1992-1 · Cited by 133
“A plausible functional link between reduced amyloidosis and preserved synaptic plasticity is further supported by the improvement of LTP observed in bigenic 5xFAD/BACE1 mice, where strong decreases in Ab levels are comparable to those found in our TgMT5 mice [66].”
ResultPeripheral Mitochondrial Dysfunction in Alzheimer’s Disease: Focus on Lymphocytes
Leuner, K., Schulz, K. L., Schuett, T., Pantel, J., Prvulovic, D., Rhein, V. F., Savaskan, E., Czech, C., Eckert, A., & Müller, W. E. (2012) · Molecular Neurobiology · doi:10.1007/s12035-012-8300-y · Cited by 143
“acetylcholine) in the hippocampus and cerebral cortex [14, 15].”
PI3 kinase signaling is involved in Aβ-induced memory loss in Drosophila
Chiang, H.-C., Wang, L., Xie, Z., Yau, A., & Zhong, Y. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0909314107 · Cited by 127
“Aβ oligomers have recently come into focus as the major pathological species of Aβ peptides, and they can cause learning defects in mice (3, 21, 22).”
BackgroundResultInfluentialAmit, T., Avramovich‐Tirosh, Y., Youdim, M. B. H., & Mandel, S. (2008) · The FASEB Journal · doi:10.1096/fj.07-8627rev · Cited by 126
“Both extracellular amyloid plaques and intracellular NFTs are central pathological hallmarks of AD (33).”
BackgroundRole of metal ions in aggregation of intrinsically disordered proteins in neurodegenerative diseases
Breydo, L., & Uversky, V. N. (2011) · Metallomics · doi:10.1039/c1mt00106j · Cited by 126
Major depression and the biological hallmarks of aging
Lorenzo, E. C., Kuchel, G. A., Kuo, C., Moffitt, T. E., & Diniz, B. S. (2022) · Ageing Research Reviews · doi:10.1016/j.arr.2022.101805 · Cited by 145
“eases such as Alzheimer’s disease and Parkinson’s disease (Haass and Selkoe, 2007).”
BackgroundMechanism mediating oligomeric Aβ clearance by naïve primary microglia
Yang, C.-N., Shiao, Y.-J., Shie, F.-S., Guo, B.-S., Chen, P.-H., Cho, C.-Y., Chen, Y.-J., Huang, F.-L., & Tsay, H.-J. (2011) · Neurobiology of Disease · doi:10.1016/j.nbd.2011.01.005 · Cited by 117
“Cerebral levels of Aβ do not correlate with the cognitive deficits in AD patients; however, the accumulation of soluble oAβ contributes to synaptic and memory deficits prior to the formation of senile plaques in the early stages of AD (Haass and Selkoe, 2007).”
López-González, I., Schlüter, A., Aso, E., Garcia-Esparcia, P., Ansoleaga, B., LLorens, F., Carmona, M., Moreno, J., Fuso, A., Portero-Otin, M., et al. (2015) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/nen.0000000000000176 · Cited by 125
Immunotherapy for Alzheimer‘s Disease: From Anti-β-Amyloid to Tau-Based Immunization Strategies
Panza, F., Frisardi, V., Solfrizzi, V., Imbimbo, B. P., Logroscino, G., Santamato, A., Greco, A., Seripa, D., & Pilotto, A. (2012) · Immunotherapy · doi:10.2217/imt.11.170 · Cited by 125
Koelsch, G. (2017) · Molecules · doi:10.3390/molecules22101723 · Cited by 125
“Aβ in various forms including soluble oligomers [114,115] disrupt synaptic transmission and cognition, induce neurotoxicity, and contribute to the overall disease process [7,16,115,116].”
BackgroundBoza-Serrano, A., Yang, Y., Paulus, A., & Deierborg, T. (2018) · Scientific Reports · doi:10.1038/s41598-018-19699-y · Cited by 124
Bioactive Polyphenols and Neuromodulation: Molecular Mechanisms in Neurodegeneration
Meo, F. D., Valentino, A., Petillo, O., Peluso, G., Filosa, S., & Crispi, S. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21072564 · Cited by 141
Structure of Crenezumab Complex with Aβ Shows Loss of β-Hairpin
Ultsch, M., Li, B., Maurer, T., Mathieu, M., Adolfsson, O., Muhs, A., Pfeifer, A., Pihlgren, M., Bainbridge, T. W., Reichelt, M., et al. (2016) · Scientific Reports · doi:10.1038/srep39374 · Cited by 124
Lafaye, P. J., Achour, I., England, P., Duyckaerts, C. J., & Rougeon, F. (2008) · Molecular Immunology · doi:10.1016/j.molimm.2008.09.008 · Cited by 131
“ADDLs show important regionally selective eurotoxicity, sparing cerebellar neurons while selectively killing ippocampal neurons and pyramidal neurons of the entorhinal corex (Haass and Selkoe, 2007).”
BackgroundPresenilins: Members of the γ-Secretase Quartets, But Part-Time Soloists Too
Wakabayashi, T., & De Strooper, B. (2008) · Physiology · doi:10.1152/physiol.00009.2008 · Cited by 123
The putative neurodegenerative links between depression and Alzheimer's disease
Wuwongse, S., Chang, R. C., & Law, A. C. K. (2010) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2010.04.005 · Cited by 133
“Furthermore, soluble oligomeric Ab appears to be involved in synaptic failure (Haass and Selkoe, 2007).”
Cassol, E., Misra, V., Dutta, A., Morgello, S., & Gabuzda, D. H. (2014) · AIDS · doi:10.1097/qad.0000000000000303 · Cited by 139
Zinc as chaperone-mimicking agent for retardation of amyloid β peptide fibril formation
Abelein, A., Gräslund, A., & Danielsson, J. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1421961112 · Cited by 122
“Miller Y, Ma B, Nussinov R (2010) Zinc ions promote Alzheimer Abeta aggregation via population shift of polymorphic states.”
BackgroundMethodInfluentialAlzheimer’s disease due to loss of function: A new synthesis of the available data
Kepp, K. P. (2016) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2016.06.004 · Cited by 124
“allegedly causes AD[128][129], although recently, specific structural features have been found to”
BackgroundMajdi, A., Sadigh-Eteghad, S., Rahigh Aghsan, S., Farajdokht, F., Vatandoust, S. M., Namvaran, A., & Mahmoudi, J. (2020) · Reviews in the Neurosciences · doi:10.1515/revneuro-2019-0089 · Cited by 122
“These peptides are vulnerable to aggregation, forming dimers, oligomers, and fibrils (Haass and Selkoe, 2007).”
BackgroundSequestration of Copper from β-Amyloid Promotes Selective Lysis by Cyclen-Hybrid Cleavage Agents
Wu, W.-H., Lei, P., Liu, Q., Hu, J., Gunn, A. P., Chen, M.-S., Rui, Y.-F., Su, X.-Y., Xie, Z.-P., Zhao, Y.-F., et al. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m804722200 · Cited by 122
Ligand Binding Thermodynamics in Drug Discovery: Still a Hot Tip?
Geschwindner, S., Ulander, J., & Johansson, P. (2015) · Journal of Medicinal Chemistry · doi:10.1021/jm501511f · Cited by 136
Hosp, F., Gutiérrez-Ángel, S., Schaefer, M. H., Cox, J., Meissner, F., Hipp, M. S., Hartl, F.-U., Klein, R., Dudanova, I., & Mann, M. (2017) · Cell Reports · doi:10.1016/j.celrep.2017.10.097 · Cited by 123
“Although it has been reported that IBs are protective by sequestering toxic soluble oligomers (Arrasate et al., 2004; Haass and Selkoe, 2007), the substantial depletion of soluble proteins observed here suggests a major impairment of protein homeostasis in the cell.”
BackgroundTargeting GSK3 signaling as a potential therapy of neurodegenerative diseases and aging
Duda, P., Wiśniewski, J., Wójtowicz, T., Wójcicka, O., Jaśkiewicz, M., Drulis-Fajdasz, D., Rakus, D., McCubrey, J. A., & Gizak, A. (2018) · Expert Opinion on Therapeutic Targets · doi:10.1080/14728222.2018.1526925 · Cited by 123
“However, recent studies have revealed that the soluble oligomers of Aβ are even more neurotoxic than amyloid plaques themselves (reviewed in [73]).”
BackgroundMaiti, P., Manna, J., Ilavazhagan, G., Rossignol, J., & Dunbar, G. L. (2015) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2015.09.020 · Cited by 138
PPARs in the central nervous system: roles in neurodegeneration and neuroinflammation
Zolezzi, J. M., Santos, M. J., Bastías‐Candia, S., Pinto, C., Godoy, J. A., & Inestrosa, N. C. (2017) · Biological Reviews · doi:10.1111/brv.12320 · Cited by 122
“…has been described as the major neurotoxic agent in AD, and the Aβ aggregates are commonly surrounded by dystrophic neurites and reactive glial cells (Lacor et al., 2004; Haass & Selkoe, 2007; Cerpa, Dinamarca & Inestrosa, 2008; Li, Shankar & Selkoe, 2010; Dinamarca, Ríos & Inestrosa, 2012).”
BackgroundYang, T., Xiao, T., Sun, Q., & Wang, K. (2017) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2017.09.001 · Cited by 120
Potential Bidirectional Relationship Between Periodontitis and Alzheimer’s Disease
Liccardo, D., Marzano, F., Carraturo, F., Guida, M., Femminella, G. D., Bencivenga, L., Agrimi, J., Addonizio, A., Melino, I., Valletta, A., et al. (2020) · Frontiers in Physiology · doi:10.3389/fphys.2020.00683 · Cited by 156
“Importantly, Aβ42 oligomers represent the most soluble and potent toxic conformers of AD (Haass and Selkoe, 2007), and their presence correlates with the severity of the disease (McLean et al., 1999).”
BackgroundAssembly, Maturation, and Trafficking of the γ-Secretase Complex in Alzheimers Disease
Dries, D., & Yu, G. (2008) · Current Alzheimer Research · doi:10.2174/156720508783954695 · Cited by 122
Deriziotis, P., André, R., Smith, D. M., Goold, R., Kinghorn, K. J., Kristiansen, M., Nathan, J. A., Rosenzweig, R., Krutauz, D., Glickman, M. H., et al. (2011) · The EMBO Journal · doi:10.1038/emboj.2011.224 · Cited by 137
“tein species (Caughey and Lansbury, 2003; Haass and Selkoe, 2007).”
BackgroundRatnaparkhi, A., Lawless, G. M., Schweizer, F. E., Golshani, P., & Jackson, G. R. (2008) · PLoS ONE · doi:10.1371/journal.pone.0002334 · Cited by 122
“Abnormal aggregation of cellular proteins is a common feature of many neurodegenerative diseases, including Alzheimer’s, Huntington’s, and Parkinson’s diseases, prion disorders, and ALS [18–22].”
BackgroundDinamarca, M. C., Sagal, J. P., Quintanilla, R. A., Godoy, J. A., Arrázola, M. S., & Inestrosa, N. C. (2010) · Molecular Neurodegeneration · doi:10.1186/1750-1326-5-4 · Cited by 121
“Presence of AChE increases Ab oligomer formation and neurotoxicity in hippocampal neurons It has been suggested that Ab oligomers are responsible for the toxic effects of Ab [ 25-27 ].”
BackgroundKokjohn, T. A., & Roher, A. E. (2009) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2009.03.002 · Cited by 122
“A growing body of evidence suggests that tertiary and quaternary structures are critical determinants of Ab pathogenicity [33], and perhaps soluble oligomers of misfolded Ab peptides represent the most toxic species [34–36].”
BackgroundPharmacological Treatment of Alzheimer Disease
Massoud, F., & Léger, G. C. (2011) · The Canadian Journal of Psychiatry · doi:10.1177/070674371105601003 · Cited by 120
Effects of Polyphenols on Brain Ageing and Alzheimer’s Disease: Focus on Mitochondria
Schaffer, S., Asseburg, H., Kuntz, S., Muller, W. E., & Eckert, G. P. (2012) · Molecular Neurobiology · doi:10.1007/s12035-012-8282-9 · Cited by 131
Duan, S., Guan, X., Lin, R., Liu, X., Yan, Y., Lin, R., Zhang, T., Chen, X., Huang, J., Sun, X., et al. (2015) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2015.02.002 · Cited by 126
Zhu, Z., Sun, Z.-Y., Ye, Y., Voigt, J., Strickland, C., Smith, E. M., Cumming, J., Wang, L., Wong, J., Wang, Y.-S., et al. (2010) · Journal of Medicinal Chemistry · doi:10.1021/jm901408p · Cited by 121
Nucifora, L. G., Burke, K. A., Feng, X., Arbez, N., Zhu, S., Miller, J., Yang, G., Ratovitski, T., Delannoy, M., Muchowski, P. J., et al. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.252577 · Cited by 121
Hatami, A., Albay, R., Monjazeb, S., Milton, S., & Glabe, C. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.594846 · Cited by 120
“However, A also forms soluble oligomeric species that are now widely believed to be the primary pathological species in AD (5, 6).”
BackgroundStructural Characteristics of α-Synuclein Oligomers
Cremades, N., Chen, S. W., & Dobson, C. (2016) · International review of cytology · doi:10.1016/bs.ircmb.2016.08.010 · Cited by 135
“…events of the amyloid self-assembly process, are inherently more damaging than their fibrillar counterparts and are believed to be the primary origins of the toxicity associated with amyloid diseases (Arrasate et al., 2004; Bucciantini et al., 2002; Haass and Selkoe, 2007; Winner et al., 2011).”
Chiral modulation of amyloid beta fibrillation and cytotoxicity by enantiomeric carbon dots
Malishev, R., Arad, E., Bhunia, S. K., Shaham‐Niv, S., Kolusheva, S., Gazit, E., & Jelinek, R. (2018) · Chemical Communications · doi:10.1039/c8cc03235a · Cited by 128
Grant, M. A., Lazo, N. D., Lomakin, A., Condron, M. M., Arai, H., Yamin, G., Rigby, A. C., & Teplow, D. B. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0705197104 · Cited by 121
The effect of increasing hydrophobicity on the self-assembly of amphipathic β-sheet peptides
Bowerman, C. J., Ryan, D. M., Nissan, D. A., & Nilsson, B. L. (2009) · Molecular BioSystems · doi:10.1039/b904439f · Cited by 244
Human apolipoprotein A–I binds amyloid-β and prevents Aβ-induced neurotoxicity
Paula-Lima, A. C., Tricerri, M. A., Brito-Moreira, J., Bomfim, T. R., Oliveira, F. F., Magdesian, M. H., Grinberg, L. T., Panizzutti, R., & Ferreira, S. T. (2009) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2008.12.003 · Cited by 121
The Role of Tau Oligomers in the Onset of Alzheimer's Disease Neuropathology
Cárdenas-Aguayo, M. D. C., Gómez-Virgilio, L., DeRosa, S., & Meraz-Ríos, M. A. (2014) · ACS Chemical Neuroscience · doi:10.1021/cn500148z · Cited by 120
Membrane‐bound β‐amyloid oligomers are recruited into lipid rafts by a fyn‐dependent mechanism
Williamson, R., Usardi, A., Hanger, D. P., & Anderton, B. H. (2008) · The FASEB Journal · doi:10.1096/fj.07-9766com · Cited by 120
Zou, Y. F., Qian, Z., Chen, Y., Qian, H., Wei, G., & Zhang, Q. (2019) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.8b00537 · Cited by 127
Rezabakhsh, A., Rahbarghazi, R., & Fathi, F. (2020) · Biosensors and Bioelectronics · doi:10.1016/j.bios.2020.112511 · Cited by 120
Alzheimer's disease: diverse aspects of mitochondrial malfunctioning.
Santos, R. X., Correia, S. C., Wang, X., Perry, G. L., Smith, M. A., Moreira, P. I., & Zhu, X. (2010) · Europe PMC (PubMed Central) · Cited by 147
Amyloid‐β Oligomers: Possible Roles as Key Neurotoxins in Alzheimer's Disease
Lublin, A. L., & Gandy, S. (2010) · Mount Sinai Journal of Medicine: A Journal of Translational and Personalized Medicine · doi:10.1002/msj.20160 · Cited by 120
High Resolution Structural Characterization of Aβ42 Amyloid Fibrils by Magic Angle Spinning NMR
Colvin, M. T., Silvers, R., Frohm, B., Su, Y., Linse, S. S., & Griffin, R. G. (2015) · Journal of the American Chemical Society · doi:10.1021/jacs.5b03997 · Cited by 120
Lublin, A. L., & Link, C. D. (2013) · Drug Discovery Today: Technologies · doi:10.1016/j.ddtec.2012.02.002 · Cited by 117
Aberrant subcellular neuronal calcium regulation in aging and Alzheimer's disease
Camandola, S., & Mattson, M. P. (2011) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2010.10.005 · Cited by 119
“Affected individuals typically become symptomatic when they are in their 40 s or 50 s. Presenilin-1 is the enzymatic component of the γ-secretase enzyme complex that cleaves APP to generate Aβ, and AD-causing mutations in presenilin-1 increases the production of Aβ42 [119].”
InfluentialWang, Y., Xia, Z., Xu, J., Wang, Y., Hou, L., Qiu, Y. L., & Chen, H. (2011) · Neuropharmacology · doi:10.1016/j.neuropharm.2011.09.016 · Cited by 127
Photophysical study of Thioflavin T as fluorescence marker of amyloid fibrils
Freire, S., de Araujo, M. H., Al‐Soufi, W., & Novo, M. (2014) · Dyes and Pigments · doi:10.1016/j.dyepig.2014.05.004 · Cited by 120
“Another disadvantage of ThT is its lack of interaction with amyloid oligomers and protofibrils [7], which have been proposed to be responsible for neurotoxicity rather than fibrils [8-10].”
BackgroundMolecular Chaperone Dysfunction in Neurodegenerative Diseases and Effects of Curcumin
Maiti, P., Manna, J., Veleri, S., & Frautschy, S. (2014) · BioMed Research International · doi:10.1155/2014/495091 · Cited by 119
PMEL Amyloid Fibril Formation: The Bright Steps of Pigmentation
Bissig, C., Rochin, L., & Van Niel, G. (2016) · International Journal of Molecular Sciences · doi:10.3390/ijms17091438 · Cited by 119
“It has been suggested that Aβ oligomers are more neurotoxic than fibrils or the senile plaques [25,26].”
BackgroundAmin, F. U., Hoshiar, A. K., Do, T. D., Noh, Y., Shah, S. A., Khan, M. S., Yoon, J., & Kim, M. O. (2017) · Nanoscale · doi:10.1039/c7nr00772h · Cited by 118
Fani Maleki, A., & Rivest, S. (2019) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2019.00355 · Cited by 119
“More precisely, several reports point out their implication in various immunopathological processes, including antigen presentation to circulating lymphocytes (Haass and Selkoe, 2007; Jack et al., 2013; Michaud et al., 2013a).”
BackgroundRegulation of liquid–liquid phase separation with focus on post-translational modifications
Luo, Y.-Y., Wu, J., & Li, Y. (2021) · Chemical Communications · doi:10.1039/d1cc05266g · Cited by 123
Role of Cholesterol in APP Metabolism and Its Significance in Alzheimer’s Disease Pathogenesis
Maulik, M., Westaway, D. A., Jhamandas, J. H., & Kar, S. (2012) · Molecular Neurobiology · doi:10.1007/s12035-012-8337-y · Cited by 129
Lee, H. G., Won, S. M., Gwag, B. J., & Lee, Y. B. (2011) · Experimental and Molecular Medicine · doi:10.3858/emm.2011.43.1.001 · Cited by 116
“Accordingly, it has been suggested that soluble oligomeric Aβ mediates all of synaptic loss and dysfunction (Haass and Selkoe, 2007), and oxidative stress (Reddy, 2009), as early events in AD pathology.”
BackgroundNew perspectives on the role of tau in Alzheimer's disease. Implications for therapy
Medina, M., & Ávila, J. (2014) · Biochemical Pharmacology · doi:10.1016/j.bcp.2014.01.013 · Cited by 146
Kim, H. Y., Kim, H. V., Jo, S., Lee, C. J., Choi, S. Y., Kim, D. J., & Kim, Y. (2015) · Nature Communications · doi:10.1038/ncomms9997 · Cited by 117
Gao, N., Dong, K., Zhao, A., Sun, H., Wang, Y., Ren, J., & Qu, X. (2016) · Nano Research · doi:10.1007/s12274-016-1000-6 · Cited by 121
“Development of a cure for AD has been hindered by a lack of understanding of both the causes and the mechanisms of disease onset and progression [1].”
BackgroundInfluentialMolybdenum Disulfide Nanoparticles as Multifunctional Inhibitors against Alzheimer’s Disease
Han, Q., Cai, S., Yang, L., Wang, X., Qi, C., Yang, R., & Wang, C. (2017) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.7b03816 · Cited by 118
On the role of sidechain size and charge in the aggregation of A β 42 with familial mutations
Yang, X., Meisl, G., Frohm, B., Thulin, E., Knowles, T. P. J., & Linse, S. S. (2018) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1803539115 · Cited by 128
A Generic Mechanism of Emergence of Amyloid Protofilaments from Disordered Oligomeric Aggregates
Auer, S., Meersman, F., Dobson, C. M., & Vendruscolo, M. (2008) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1000222 · Cited by 118
“Given the close link between this phase of amyloid formation and the neurotoxicity of the structural species involved [1,8, 10 ,23], we investigated here the competition between ordered and disordered aggregation of polypeptide chains.”
BackgroundPeptides for Therapy and Diagnosis of Alzheimer's Disease
Funke, S. A., & Willbold, D. (2012) · Current Pharmaceutical Design · doi:10.2174/138161212799277752 · Cited by 130
“More recent studies support that diffusable A oligomers including protofibrils, prefibrillar aggregates and so called A -derived diffusible ligands (ADDLs), are the major toxic species during disease development and progression [12-14].”
BackgroundAndrographolide reduces cognitive impairment in young and mature AβPPswe/PS-1 mice
Serrano, F. G., Tapia-Rojas, C., Carvajal, F. J., Hancke, J., Cerpa, W., & Inestrosa, N. C. (2014) · Molecular Neurodegeneration · doi:10.1186/1750-1326-9-61 · Cited by 116
“Such effects are triggered by A β oligomers, which are soluble and toxic molecular forms of A β [6,25,59,60]; however, these effects might induce GSK-3 β inhibition, which might be an independent mechanism (Figure 7).”
Decreased Complexity in Alzheimer's Disease: Resting-State fMRI Evidence of Brain Entropy Mapping
Wang, B., Niu, Y., Miao, L., Cao, R., Yan, P., Guo, H., Li, D., Guo, Y., Yan, T., Wu, J., et al. (2017) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2017.00378 · Cited by 116
“The neuropathology of AD is characterized by neuronal loss and the appearance of neuritic plaques containing amyloid-β-peptide and neurofibrillary tangles (Haass and Selkoe, 2007).”
BackgroundExploring ER stress response in cellular aging and neuroinflammation in Alzheimer's disease
Uddin, M. S., Yu, W. S., & Lim, L. W. (2021) · Ageing Research Reviews · doi:10.1016/j.arr.2021.101417 · Cited by 135
Zussy, C., Brureau, A., Keller, E., Marchal, S., Blayo, C., Delair, B., Ixart, G., Maurice, T., & Givalois, L. (2013) · PLoS ONE · doi:10.1371/journal.pone.0053117 · Cited by 116
Sequence-Based Prediction of Protein Solubility
Agostini, F., Vendruscolo, M., & Tartaglia, G. G. (2011) · Journal of Molecular Biology · doi:10.1016/j.jmb.2011.12.005 · Cited by 120
The role of intracellular amyloid β in Alzheimer's disease
Li, M., Chen, L., Lee, D. H. S., Yu, L., & Zhang, Y. (2007) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2007.08.002 · Cited by 135
Insulin Resistance Exacerbates Alzheimer Disease via Multiple Mechanisms
Wei, Z., Koya, J., & Reznik, S. E. (2021) · Frontiers in Neuroscience · doi:10.3389/fnins.2021.687157 · Cited by 115
“Furthermore, soluble oligomeric forms of amyloid β-protein are the primary toxic species (Haass and Selkoe, 2007; Selkoe and Hardy, 2016) that have been shown to cause synaptic damage and neuronal cell death in both an APP knock-out mouse model and post-mortem human brains from patients with AD…”
BackgroundGanesan, D., & Cai, Q. (2021) · Biochemical Journal · doi:10.1042/bcj20200917 · Cited by 131
Secretory Outposts for the Local Processing of Membrane Cargo in Neuronal Dendrites
Hanus, C., & Ehlers, M. D. (2008) · Traffic · doi:10.1111/j.1600-0854.2008.00775.x · Cited by 116
“The processing of the amyloid precursor protein (APP) during b-amyloid (Ab) production occurs during trafficking through the early secretory pathway and/or endocytic compartments (67), but the exact modalities of APP production in neurons are still not fully delineated.”
BackgroundSoluble apoE/Aβ complex: mechanism and therapeutic target for APOE4-induced AD risk
Tai, L. M., Mehra, S., Shete, V., Estus, S., Rebeck, G. W., Bu, G., & LaDu, M. J. (2014) · Molecular Neurodegeneration · doi:10.1186/1750-1326-9-2 · Cited by 116
“cognitive dysfunction in AD, an emerging consensus is that soluble Aβ42 and oAβ represent major proximal, neurotoxic species in AD [15,20].”
The unfolded protein response in Alzheimer’s disease
Cornejo, V. H., & Hetz, C. A. (2013) · Seminars in Immunopathology · doi:10.1007/s00281-013-0373-9 · Cited by 129
“Aβ peptide is generated by the proteolysis of APP by β- and γ-secretases [10] (Fig.”
BackgroundNabers, A., Ollesch, J., Schartner, J., Kötting, C., Genius, J., Hafermann, H., Klafki, H., Gerwert, K., & Wiltfang, J. (2016) · Analytical Chemistry · doi:10.1021/acs.analchem.5b04286 · Cited by 115
Baglietto-Vargas, D., Forner, S., Cai, L., Martini, A. C., Trujillo-Estrada, L., Swarup, V., Nguyen, M. M. T., Do Huynh, K., Javonillo, D. I., Tran, K. M., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-22624-z · Cited by 112
Wahlström, A., Hugonin, L., Perálvarez‐Marín, A., Jarvet, J., & Gräslund, A. (2008) · The FEBS Journal · doi:10.1111/j.1742-4658.2008.06643.x · Cited by 114
The Molecular Basis of Distinct Aggregation Pathways of Islet Amyloid Polypeptide
Wei, L., Jiang, P., Xu, W., Li, H., Zhang, H., Yan, L., Chan‐Park, M. B. E., Liu, X., Tang, K., Mu, Y., et al. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.166678 · Cited by 120
Mallory–Denk-bodies: Lessons from keratin-containing hepatic inclusion bodies
Strnad, P., Zatloukal, K., Stumptner, C., Kulaksiz, H., & Denk, H. (2008) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2008.08.008 · Cited by 131
Noncanonical function of an autophagy protein prevents spontaneous Alzheimer’s disease
Heckmann, B. L., Teubner, B. J. W., Boada-Romero, E., Tummers, B., Guy, C., Fitzgerald, P., Mayer, U., Carding, S., Zakharenko, S. S., Wileman, T., et al. (2020) · Science Advances · doi:10.1126/sciadv.abb9036 · Cited by 114
Pujol-Pina, R., Vilaprinyó-Pascual, S., Mazzucato, R., Arcella, A., Vilaseca, M., Orozco, M., & Carulla, N. (2015) · Scientific Reports · doi:10.1038/srep14809 · Cited by 114
Are N- and C-terminally truncated Aβ species key pathological triggers in Alzheimer's disease?
Dunys, J., Valverde, A., & Checler, F. (2018) · Journal of Biological Chemistry · doi:10.1074/jbc.r118.003999 · Cited by 114
Funke, S. A., van Groen, T., Kadish, I., Bartnik, D., Nagel-Steger, L., Brener, O., Sehl, T., Batra-Safferling, R., Moriscot, C., Schoehn, G., et al. (2010) · ACS Chemical Neuroscience · doi:10.1021/cn100057j · Cited by 114
“In the sections that were stained for human Aβ(4-10) immunoreactivity, the total Aβ load in the hippocampus and frontal cortex was measured.”
BackgroundMethodGao, Y., Li, C., Yin, J., Shen, J., Wang, H., Wu, Y., & Jin, H. (2011) · Environmental Toxicology and Pharmacology · doi:10.1016/j.etap.2011.12.022 · Cited by 119
The Non-Core Regions of Human Lysozyme Amyloid Fibrils Influence Cytotoxicity
Mossuto, M. F., Dhulesia, A., Devlin, G., Frare, E., Kumita, J. R., de Laureto, P. P., Dumoulin, M., Fontana, A., Dobson, C. M., & Salvatella, X. (2010) · Journal of Molecular Biology · doi:10.1016/j.jmb.2010.07.005 · Cited by 114
Green Tea Extracts EGCG and EGC Display Distinct Mechanisms in Disrupting Aβ42 Protofibril
Zhan, C., Chen, Y., Tang, Y., & Wei, G. (2020) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.0c00277 · Cited by 115
Abelein, A., Abrahams, J. P., Danielsson, J., Gräslund, A., Jarvet, J., Luo, J., Tiiman, A., & Wärmländer, S. K. T. S. (2014) · JBIC Journal of Biological Inorganic Chemistry · doi:10.1007/s00775-014-1131-8 · Cited by 122
Amiri, H., Saeidi, K., Borhani, P., Manafirad, A., Ghavami, M., & Zerbi, V. (2013) · ACS Chemical Neuroscience · doi:10.1021/cn4001582 · Cited by 113
Sathya, M., Palanisamy, P., Chennakesavan, K., Ponnusamy, M., Jayachandran, K. S., & Anusuyadevi, M. (2012) · Clinica Chimica Acta · doi:10.1016/j.cca.2012.08.013 · Cited by 125
“, the main constituent of amyloid plaques, is responsible for the initiation of a neurotoxic cascade that ultimately leads to neuronal death and dementia [6,8,9].”
BackgroundDavtyan, H., Ghochikyan, A., Petrushina, I., Hovakimyan, A., Davtyan, A., Poghosyan, A., Marleau, A. M., Movsesyan, N., Kiyatkin, A., Rasool, S., et al. (2013) · The Journal of Neuroscience · doi:10.1523/jneurosci.4672-12.2013 · Cited by 112
“Increasing evidence suggests that soluble (or diffusible) A oligomers mediate different toxic pathways in AD, such as tau hyperphosphorylation (De Felice et al., 2008), impairment of memory, and neuronal death (Lesne et al., 2006; Haass and Selkoe, 2007; Shankar et al., 2008).”
BackgroundYahi, N., Aulas, A., & Fantini, J. (2010) · PLoS ONE · doi:10.1371/journal.pone.0009079 · Cited by 112
“Non-fibrillar oligomers of Ab are also toxic [5], and it is difficult to assess which molecular species among dimers, oligomers and fibrils are the most pathogenic.”
Background
Metadata
- Authors
- Haass, C., & Selkoe, D. J.
- Affiliations
- Adolf-Butenandt-Institut für Physiologische Chemie, Physikalische Biochemie und Zellbiologie (DE)
- Venue
- Nature Reviews Molecular Cell Biology
- Published
- 2007-02
- Volume
- 8
- Issue
- 2
- Pages
- 101-112
- ISSN
- 1471-0072 (ISSN-L)
- 1471-0080
- OpenAlex
- W1980825524
- Cited by
- 4,744
- References
- 135
- Citations by year
- 2026: 135 · 2025: 171 · 2024: 165 · 2023: 170 · 2022: 195 · 2021: 239 · 2020: 273 · 2019: 247 · 2018: 276 · 2017: 290 · 2016: 331 · 2015: 313 · 2014: 285 · 2013: 307 · 2012: 327
- FWCI
- 25.58
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Reviews Molecular Cell Biology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Keywords
- Alzheimer's disease, neurodegeneration, protein misfolding, protein aggregation, synaptic dysfunction, synaptic plasticity, Parkinson's disease, Huntington's disease, prion disease, neuronal dysfunction
- MeSH terms
- Alzheimer Disease, Cell Membrane, Humans, Memory Disorders, Models, Biological, Nerve Degeneration, Solubility, Synapses, Signal Transduction, Amyloid beta-Peptides, Protein Folding
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.